Holen Sie sich die Stockscreener-App
0.7885
0.00%
0.00
Schlusskurs vom Vortag:
$0.7885
Offen:
$0.8193
24-Stunden-Volumen:
43,156
Relative Volume:
0.15
Marktkapitalisierung:
$38.91M
Einnahmen:
$8.72M
Nettoeinkommen (Verlust:
$-6.83M
KGV:
-4.7817
EPS:
-0.1649
Netto-Cashflow:
$-6.27M
1W Leistung:
-6.43%
1M Leistung:
-3.04%
6M Leistung:
-11.31%
1J Leistung:
-22.70%
1-Tages-Spanne:
$0.7501
$0.8193
1-Wochen-Bereich:
$0.75
$0.8461
52-Wochen-Spanne:
$0.3954
$1.16
Neuroone Medical Technologies Corp Stock (NMTC) Company Profile
Firmenname
Neuroone Medical Technologies Corp
Sektor
Branche
Telefon
(952) 426-1383
Adresse
7599 ANAGRAM DR, EDEN PRAIRIE
Compare NMTC vs PSNYW, GOODO, SHMD, DWLD, QQQE
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| 0.99 | 0 | 0 | 0 | 0 | 0.00 | |
PSNYW
Polestar Automotive Holding Uk
|
4.09 | 378.34M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
GOODO
Gladstone Commercial Corporation
|
19.91 | 372.90M | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
6.47 | 383.66M | 0 | 0 | 0 | 0.00 |
|
DWLD
Davis Select Worldwide ETF
|
44.24 | 0 | 0 | 0 | 0 | 0.00 |
|
QQQE
Direxion NASDAQ-100 Equal Weigh
|
99.87 | 0 | 0 | 0 | 0 | 0.00 |
Neuroone Medical Technologies Corp Stock (NMTC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-05 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2022-03-29 | Herabstufung | Craig Hallum | Buy → Hold |
Neuroone Medical Technologies Corp Aktie (NMTC) Neueste Nachrichten
Neuroone medical director Christianson sells $10k in NMTC stock - Investing.com
NeuroOne(R) to Present at the Oppenheimer 36th Annual Healthcare MedTech & Services Conference March 17, 2026 at 1:20 p.m. Eastern Time - Yahoo Finance
NeuroOne(R) Issues Shareholder Letter and Provides Corporate Update - Yahoo Finance
JonesTrading Begins Coverage on NeuroOne Medical Technologies (NASDAQ:NMTC) - Defense World
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
Neuroone medical chief business officer buys $670k in NMTC By Investing.com - Investing.com South Africa
Neuroone medical chief business officer buys $670k in NMTC - Investing.com
NeuroOne Medical Technologies Officer Acquires 1 Million Shares - TradingView
NEUROONE (NASDAQ: NMTC) CBO buys 1M shares and receives 500K options - Stock Titan
NeuroOne (NMTC) Chief Business Officer files initial Form 3 insider report - Stock Titan
NeuroOne(R) Appoints David Wambeke as Chief Business Officer; Concurrently Completes Insider Purchase of 1 Million Shares - Yahoo Finance
Neuroone Medical stock initiated at Buy by Jones Trading - Investing.com Canada
Jones Trading Initiates Coverage on NMTC with Buy Rating and $1. - GuruFocus
NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) Sees Large Growth in Short Interest - Defense World
NMTC Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
NeuroOne (NMTC) schedules 2026 shareholder meeting and Rule 14a-8 cutoff - Stock Titan
Aug Final Week: What dividend growth rate does NeuroOne Medical Technologies Corporation offerJuly 2025 Big Picture & High Conviction Investment Ideas - baoquankhu1.vn
Wall Street Zen Upgrades NeuroOne Medical Technologies (NASDAQ:NMTC) to Sell - Defense World
NeuroOne Medical Technologies Q1 Earnings Call Highlights - Defense World
NeuroOne Earnings Call Balances Growth With Cash Strain - TipRanks
NeuroOne Medical Technologies Corp (NMTC) Q1 2026 Earnings Call - GuruFocus
Earnings call transcript: NeuroOne Medical beats Q1 2026 EPS forecast, stock dips - Investing.com Nigeria
NeuroOne Medical Technologies Corporation Q1 2026 Earnings Call Summary - Yahoo Finance
NeuroOne (NMTC) Q1 2026 Earnings Call Transcript - The Globe and Mail
NeuroOne Reports Fiscal Q1 2026 Financial Results - TradingView
NEUROONE MEDICAL TECHNOLOGIES Corp SEC 10-Q Report - TradingView
What to Expect from NeuroOne Medical Tech's Earnings - Benzinga
NeuroOne Medical Technologies Corp (NMTC) Q1 2026: Everything Yo - GuruFocus
NeuroOne Medical Technologies Co. (NASDAQ:NMTC) Short Interest Update - 富途牛牛
Minne InnoNeuroOne CEO Dave Rosa talks uplisting on Nasdaq, year ahead - The Business Journals
NeuroOne(R) to Report First Quarter Fiscal Year 2026 Financial Results on Tuesday, February 17 at 8:30 a.m. Eastern Time - The Globe and Mail
Inside NeuroOne's brain electrode technology - MobiHealthNews
NeuroOne electrodes target motor issues and pain - MobiHealthNews
How NeuroOne's minimally invasive brain technology works - Healthcare IT News
Will NeuroOne Medical Technologies Corporation stock outperform tech sector in 2025Market Performance Recap & Verified Short-Term Trading Plans - Улправда
Will NeuroOne Medical Technologies Corporation stock deliver better than expected guidance2025 Key Lessons & Growth Focused Entry Point Reports - Улправда
Will NeuroOne Medical Technologies Corporation stock see insider buying2025 Earnings Surprises & Low Risk High Reward Ideas - Улправда
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Best Momentum Stocks to Buy for January 6th - Yahoo Finance
New Strong Buy Stocks for January 6th - Yahoo Finance
NeuroOne Medical Technologies Q4 Earnings Call Highlights - Defense World
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
NeuroOne appoints Penumbra executive Jason Mills to board - Investing.com
NeuroOne(R) Appoints Jason Mills to the Board of Directors - Yahoo Finance
Is NeuroOne Medical Technologies Corporation stock in correction or buying zoneWeekly Trade Analysis & Technical Confirmation Trade Alerts - Улправда
Will NeuroOne Medical Technologies Corporation stock benefit from upcoming earnings reportsTrade Entry Report & Low Risk High Win Rate Stock Picks - ulpravda.ru
NeuroOne Medical Technologies Corp (NMTC) Q4 2025 Earnings Call Highlights: Record Revenue ... By GuruFocus - Investing.com Canada
NeuroOne Medical Technologies Corp (NMTC) Q4 2025 Earnings Call - GuruFocus
NeuroOne Medical Technologies Corp (NMTC) Q4 2025 Earnings Call Highlights: Record Revenue ... - Yahoo Finance
Is NeuroOne Medical Technologies Corporation stock attractive for hedge fundsJuly 2025 Momentum & High Return Stock Watch Alerts - Улправда
Earnings call transcript: NeuroOne Q4 2025 sees revenue surge, stock rises - Investing.com
Finanzdaten der Neuroone Medical Technologies Corp-Aktie (NMTC)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.81%
0.75%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):